TD Cowen analyst Gary Taylor raised the firm’s price target on UnitedHealth to $605 from $555 and keeps an Outperform rating on the shares. The firm raising its 2024-25 EPS due to stronger commercial and MA enrollment assumptions as well as larger corporate G&A reductions as an offset to OptumHealth margins that they anticipate will remain below long-term guidance of 8-10%.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on UNH:
- Wayfair upgraded, JD.com downgraded: Wall Street’s top analyst calls
- CVS biggest beneficiary of Medicare Advantage stars scores, says BofA
- UnitedHealth price target raised to $596 from $572 at RBC Capital
- UnitedHealth price target raised to $660 from $650 at BofA
- UnitedHealth price target raised to $584 from $580 at Piper Sandler